An interventional study of Repeated behavioural assessment and Act-Pass paradigm in Acute Brain Injury Coma, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 17 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Brain Injuries with a site in France — 18 open to participants now, 19 under way, none of them phase 3. Brain Injuries · France.
Among the 72 studies in Brain Injuries with a site in France, this one is the 14th largest by planned enrollment of the 36 interventional ones that give a count, is one of 4 that started in 2024, is one of 26 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 58th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →18 of the 72 studies in Brain Injuries with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Saint Etienne · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Centre Hospitalier St Anne · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 17 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 41 across 613 interventional studies indexed under Brain Injuries.
Median enrollment 46 across the 36 interventional studies, 124 across the 36 observational. Of the 45 that completed or were terminated, 2 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 72 have an industry lead sponsor. The 10 most frequent:
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
Hospices Civils de Lyon has 4 studies filed under Brain Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Brain Injuries with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07085403Hopitaux de Saint-MauriceLet's CO-OPerate! Together we Are Stronger | 2027-05-01 |
| NCT07127224Centre Hospitalier St AnneConsciousness Prognosis Evaluation Using Olfactory Stimulations in Comatose Patients) | 2027-05-05 |
| NCT07450404Central Hospital, Nancy, FrancePK/PD Target Attainment of Ceftriaxone for the Prevention of Early Ventilator-associated Pneumonia in Neurologically Injured Patients | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 72 studies in Brain Injuries with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Acute brain injury is a major cause of admission to intensive care units, as well as of mortality and morbidity, worldwide and for all age groups. With most patients surviving these injuries thanks to recent medical advances, society is facing not only the growing burden of disability, but above all the ethical issues involved in withdrawal of life-sustaining therapies (WSLT). To resolve this dilemma, effective treatment would be necessary, but this is hampered by our limited knowledge of the pathophysiological mechanisms of the natural history of coma, from onset to recovery. A more systematic description of coma awakening using a multimodal battery in intensive care unit patients would enable us to refine the awakening and re-emergence of consciousness and define appropriate biomarkers for selecting candidates in interventional studies.
The investigators hypothesize that the current postulate of successive stages (i.e. from one clinical class to the next) of coma recovery is incomplete, as it does not take into account the rhythmic nature of wakefulness. The investigators propose that the best correlate of the natural history of coma recovery is a gradual shift from the loss of physiological cycles to a circadian rhythmicity of arousal indices (behavioural and neurophysiological) and a wide amplitude of metric fluctuations in assessing content richness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Group 1
Group 2
Absence of severe disorder of consciousness but possibility of minimal alteration of the initial Glasgow score (GCS between 9 and 15) with no time limit, with a stratification of three consecutive patient populations distinguished by the initial neurological alteration:
Group 3
Disturbance of consciousness defined by an absence of communication or an absence of functional use of objects (for patients with aphasia), i.e. the two signs that could indicate emergence from the pauci-relational state, which includes patients presenting :
Persistent within the following timeframe
Exclusion Criteria:
Group 1
Group 2
Epileptic seizures on admission or during the stay
Group 3
Epileptic seizures during the week preceding inclusion:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
50 patients in the initial phase of acute brain injury with disturbed consciousness, hospitalized in the Neurological Intensive Care Unit and at risk of delayed awakening
Behavioral: Repeated behavioural assessment · Behavioral: Act-Pass paradigm · Behavioral: Biological measures of circadian and monoamines biomarkers · Behavioral: Transcriptomic and genomic analysis · Behavioral: Polysomnography with concomitant environment recording · Behavioral: Actimetry · Behavioral: Morphological MRI · Behavioral: Assessment of correlation between patients' behaviour and neurophysiological markers of consciousness.
20 patients in the initial phase of brain damage WITHOUT disturbance of consciousness, hospitalized in the Neurological Intensive Care Unit and presenting similar causes of brain damage.
Behavioral: Repeated behavioural assessment · Behavioral: Act-Pass paradigm · Behavioral: Biological measures of circadian and monoamines biomarkers · Behavioral: Transcriptomic and genomic analysis · Behavioral: Polysomnography with concomitant environment recording · Behavioral: Actimetry · Behavioral: Morphological MRI · Behavioral: Assessment of correlation between patients' behaviour and neurophysiological markers of consciousness.
20 patients in the sub-acute or chronic phase of a consciousness disorder and admitted to the Post-Resuscitation Rehabilitation Service.
Behavioral: Repeated behavioural assessment · Behavioral: Act-Pass paradigm · Behavioral: Biological measures of circadian and monoamines biomarkers · Behavioral: Transcriptomic and genomic analysis · Behavioral: Polysomnography with concomitant environment recording · Behavioral: Actimetry · Behavioral: Morphological MRI · Behavioral: Assessment of correlation between patients' behaviour and neurophysiological markers of consciousness.
One CRS-R per visit * 4 SECONDs * Eye tracking during every clinical assessment * Recording every 2-4h of the Glasgow Coma Score * Recording every 2h of the temperature and pupillometer reactivity to light
Before and after sedation withdrawal Assessment of infra-clinical response to an active paradigm (attention focalisation or diversion).
Systematic urinary sampling every 2 hours for melatonin, cortisol and monoamines metabolites
Definition of the peripheral cellular clock by 2 transcriptomic measures Constitution of a genomic biobank to analyse the cofounding factors for circadian disruption and differential clinical recovery
One 48h polysomnography for the first visit \+ 3\* 24h polysomnography for each visit Synchronised recordings of light, sound, activity in patients' rooms
Continuous recording of movements at the wrist during 7 days after sedation withdrawal
Precise description of brain lesion by a 3T MRI within the 1st week after sedation withdrawal
Video recording of spontaneous patients' movements in the bed and synchronized during 2h with high-density EEG.
Consciousness outcome
Coma Recovery Scale - revised used to define 4 possible consciousness outcomes (the best observed before death if the patient died at the date of assessment): * Coma * Unresponsive Wakefulness Syndrome * Minimally Conscious State * Exit-Minimally Conscious State (conscious patient)
Time frame: 2, 3, 4,6 months post injury
Functional outcome
Glasgow Outcome Scale (GOS) Glasgow Outcome Scale Extended (GOSE) Minimum score 1 and maximum score 5. The lowest score is 5.
Time frame: GOS: 2, 3, 4,6 months post injury GOSE: 6 months post injury
Cognitive outcome
MOCA scale The MOCA is a short 30-question test that assesses several cognitive domains and allows for early detection of cognitive disorders. The MOCA test takes about 10-15 minutes to administer and consists of several sections, the first of which is an assessment of orientation in time and space. Then there are tasks that assess memory, concentration and reasoning ability, as well as language and visuospatial ability tasks. The MOCA score can range from 0 to 30 points, with a score of 26 points or more considered normal.
Time frame: 6 months post injury
Quality of life outcome SF-36 scale
At the end, a score for each dimension of the SF-36 was calculated, ranging from 0 to 100. A low score reflects a perception of poor health, loss of function, presence of pain. A high score reflects a perception of good health, absence of functional deficit, and pain (3,6,7)
Time frame: 6 months post injury
Started Dec 2024 (actual). Primary completion is estimated for Jun 2029, 54 months after the start.
Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 54 months is above that.
Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.